Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Heron Therapeutics (HRTX) Profit After Tax: 2009-2024

Historic Profit After Tax for Heron Therapeutics (HRTX) over the last 16 years, with Dec 2024 value amounting to -$13.6 million.

  • Heron Therapeutics' Profit After Tax fell 260.87% to -$17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.6 million, marking a year-over-year increase of 51.45%. This contributed to the annual value of -$13.6 million for FY2024, which is 87.72% up from last year.
  • Heron Therapeutics' Profit After Tax amounted to -$13.6 million in FY2024, which was up 87.72% from -$110.6 million recorded in FY2023.
  • Over the past 5 years, Heron Therapeutics' Profit After Tax peaked at -$13.6 million during FY2024, and registered a low of -$227.3 million during FY2020.
  • For the 3-year period, Heron Therapeutics' Profit After Tax averaged around -$102.1 million, with its median value being -$110.6 million (2023).
  • As far as peak fluctuations go, Heron Therapeutics' Profit After Tax decreased by 11.00% in 2020, and later soared by 87.72% in 2024.
  • Over the past 5 years, Heron Therapeutics' Profit After Tax (Yearly) stood at -$227.3 million in 2020, then grew by 2.90% to -$220.7 million in 2021, then grew by 17.52% to -$182.0 million in 2022, then skyrocketed by 39.26% to -$110.6 million in 2023, then soared by 87.72% to -$13.6 million in 2024.